Skip to main content

Cancer Research

Investigating the Hallmarks of Cancer Cells

Agilent Seahorse XF technology measures the hallmarks of cancer cells: oncogene reprogramming of metabolism, substrate preference of tumor cells, and metabolic phenotypes. Cancer cells exhibit a phenotype that reflects their metabolic needs, and researchers are using XF technology to explore these metabolic changes to increase their understanding of cancer pathogenesis.

Learn more about How XF Technology Works

Click to search either the Seahorse XF Publications Database or the Seahorse Cell Reference Database

For Research Use Only. Not for use in diagnostic procedures.